Editor

Allan E. Dittmer

Contributing Editors

Issue 13
Fall/Winter 2006

Russell A. Prough
Russell Barnett
Jeff Jack
Mark French
John Gilderbloom
Peter B. Meyer
J. Cam Metcalf
David M. Wicks

Graphic Designer

Tim Dittmer

The Kentucky Institute for the
Environment and Sustainable
Development (KIESD) was
created in July 1992 within the
Office of the Vice President
for Research, University of
Louisville. The Institute
provides a forum to conduct
interdisciplinary research, applied
scholarly analysis, pubic service
and educational outreach on
environmental and sustainable
development issues at the local,
state, national and international
levels.
KIESD is comprised of eight
thematic program centers:
Environmental Education,
Watershed Research,
Environmental Law, Sustainable
Urban Neighborhoods, Pollution
Prevention, Environmental and
Occupational Health Sciences,
Environmental Policy and
Management, and Environmental
Engineering.
Sustain is published semiannually by the Kentucky
Institute for the Environment
and Sustainable Development,
University of Louisville,
203 Patterson Hall,
Louisville, Kentucky 40292.
Send electronic correspondence
to r.barnett@louisville.edu

The
Kentucky Institute
for the
Environment
and Sustainable
Development

The Contribution of Air Pollution to the
Burden of Cardiovascular Disease............................................. 3
by J. Patrick Mastin
The Role of Matabolism in Protection
Against Cardiotoxic Compounds............................................... 6
by Russell A. Prough, Immaculate Amunom,
and Daniel J. Conklin
Environmental Pollution: Relationship to
Cardiac Dysfunction and Heart Disease.................................. 12
by Sumanth D. Prabhu
Getting to the Heart of Pollution: Is Pollution
a New Risk Factor for Cardiovascular Disease?...................... 17
by Bradford G. Hill, Oleg Barski, and Aruni Bhatnagar
Not Magic, but Mass Spectrometry to
Monitor Interactions of Environmental
Pollutants and Cardiovascular Components............................ 24
by William M. Pierce, Jr, Jian Cai, Ned Smith,
Delano Turner, Kevin G. Taylor, and Jason R. Neale
Cover Photo: Interstate 65 in Louisville, Kentucky.

The University of Louisville is an equal
opportunity institution and does not discriminate
against persons on the basis of age, religion, sex,
disability, color, national origin or veteran status.
This publication was prepared by the
University of Louisville and printed
with state funds KRS 57.375.

Fall/Winter 2006

This Publication is printed on recycled paper.





Fall/Winter 2006

The Contribution of Air Pollution to the
Burden of Cardiovascular Disease
J. Patrick Mastin
Division of Extramural Research and Training
National Institute of Environmental Health and Safety
Research Triangle Park, NC.
The first people to experience the health effects of air
pollution were undoubtedly the first people to use fire for
cooking and staying warm. However, it wasn’t until people
began to live together in cities and began to burn coal and
other fossil fuels, for industrial processes and transportation
as well as food and warmth, that medical professions began
to seriously consider the adverse health effects of these
combustion products. Now that our society and economy are
dependent on the benefits of burning these fuels, we live in an
atmosphere that is made up, not only of “natural” gases (such
as nitrogen, oxygen, carbon dioxide) and aerosols (such as
wind-borne dust), but also potentially harmful gases, such as
ozone, aldehydes, and sulfur dioxide, and aerosols consisting
of microscopic droplets of such chemicals as sulfates and
nitrates and carbon particles (“soot”) to which chemicals
such as hydrocarbons and heavy metals are adsorbed. This
is especially true in large metropolitan and industrial areas.
As a result of this increase in air pollution, the biomedical
community began, especially in the last century, to investigate
the health effects of air pollution on the large number of
people who are now exposed.

Association (3), suggest that the cardiovascular community
is recognizing the potential contribution of environmental
exposure to risk for CVD.

For obvious reasons, most research was initially focused
on the toxic effects of air pollution on the lungs, and it was
shown that air pollution can exacerbate chronic lung diseases,
including asthma, in adults and children. However, in the
early and middle 1990s researchers began to find, somewhat
surprisingly, that air pollution also appeared to be associated
with mortality from cardiovascular disease (CVD). Two
landmark studies in this area – the Six Cities Study and
the American Cancer Society Study – that looked at large
populations of people exposed to a wide range of levels of
pollution strongly suggested that cardiovascular disease was
associated especially with the particulate component (often
referred to as “particulate matter” or “PM”) of air pollution
(1,2). Since those initial studies, many reports have confirmed
a robust link between exposure to PM and cardiovascular
disease and death, and more recent reports have also
suggested a connection between ozone exposure and CVD.
Publications in leading cardiovascular journals and other high
impact journals, including a Scientific Statement on “Air
Pollution and Cardiovascular Disease by the American Heart

However, epidemiologic associations, although they may
be strong, don’t completely make the case. There is also the
issue of “biological plausibility”: does the association make
sense based on what we know, or what we can learn, about
the how cardiovascular diseases develop? In other words,
are there pathologic mechanisms to explain the association?
This represents a major focus of research in the area of
pollution-related CVD.
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The significance of an air pollution–CVD connection
could be quite profound. While the associations that have
been seen are fairly small, often less than 1% increase in risk
per 10 microgram/cubic milliliter difference in PM levels,
many people are exposed to air pollution, so the cumulative
effect could be great. In addition, cardiovascular disease
(sometimes referred to simply as “heart disease”) is the
primary cause of death in the industrialized world. According
to the American Heart Association, 927,448 people died of
CVD in the United States in 2002. This represents a death
rate of 320.5 per 100,000 people and accounts for 38.0% of
all deaths (4). Depending on how significant a risk factor air
pollution exposure proves to be, relative to the other known
risk factors – age, race, lifestyle factors (such as smoking,
physical inactivity, and diet), serum lipids, and family history
– reduction in air pollution levels could be a means for
significantly reducing the burden of CVD.

Several mechanisms to explain air pollution toxicity
have been proposed and all have data to support them.
These ideas developed mostly from research on the effects
of PM. The most obvious explanation is direct toxicity to
the cardiovascular tissue. This seems most plausible for
chemicals that can be solubilized in the lung after inhalation,
such as aldehydes and metals dissolved from particulate
matter, and transported to the cardiovascular tissues, most
likely through the blood. However, there is also evidence
that the particles can be translocated intact from the lung to
vascular and cardiac tissues. This is especially true for the



smaller, so-called, ultrafine particles. Once in the vicinity of
the CV tissue, the pollutants might adversely affect the tissue
by causing or increasing local inflammation, interfering with
metabolic processes, disrupting ion channel function, etc.
The pollutants might also cause local inflammatory responses
in the lung that result in production of inflammatory mediators
that could be transported to the cardiovascular tissues,
thus affecting function. Either of these two mechanisms
might explain experimental data showing an increase in
atherosclerosis in animals exposed to PM (5).
A third hypothesis is that pollutants might trigger nerve
endings in the lung which subsequently send impulses to the
brain and in turn back to the heart. These nerves are part of the
autonomic nervous system and influence how the heart beats.
This has been offered as a mechanism to explain evidence
that PM in the lung can affect the rhythm of the heart. It is
of course likely that all of these mechanisms play a role.
There is one more important question that research
needs to answer: Why are individuals affected differently
by exposure to air pollution? What are the individual
“susceptibility factors” that make one person more at risk
from exposure to air pollution? Evidence has begun to
suggest that the elderly and those with pre-existing disease
are most affected. It is also reasonable to suspect that air
pollution might worsen the effects of the “traditional” risk
factors for CVD, such as smoking and diet. And finally, an
active area of research in all areas of disease susceptibility is
the role of genetics. A coordinated approach between basic
laboratory science and population-based science is needed
to fully resolve this question.
In the articles that follow, researchers from the University
of Louisville, who are active this area of research, discuss
many of the important considerations involved in trying to
understand air pollution-related cardiovascular disease. First,
Drs. Prough, Amunom, and Conklin provide an overview
of the chemistry of some chemicals in air pollution, such as
polycyclic aromatic hydrocarbons and aldehydes. In addition,
they outline the metabolic processes the body uses to try to
eliminate these exogenous chemicals, and importantly, how
the processes sometime create metabolites that are more toxic
than the original compound. Finally, they discuss some of the
consequences of the chemical reactions of these compounds
with DNA and proteins. In another chapter, Pierce and
coworkers describe the use of mass spectrometry in defining
protein adducts and their contribution to cardiotoxicology.
Drs. Hill, Barski, and Bhatnagar then review some
of the epidemiologic findings linking air pollution and



cardiovascular disease, as well as data linking occupational
exposures to cardiovascular disease. They also discuss work
in their lab and in others’ that is looking at how exposure
to aldehydes can cause alterations in serum lipid profiles,
a known risk factor for cardiovascular disease in humans,
and can reduce the body’s ability to protect the heart against
ischemia, a common cause of heart attacks. Dr. Prabhu’s
overview focuses more on the effects of particulate matter,
for which there is the most data related to cardiovascular
disease. In addition, he briefly discusses some of his
research on aldehydes which shows that acrolein, a common
aldehyde in various kinds of smoke including tobacco smoke,
depresses the heart’s ability to function optimally, perhaps
due to its effect on the protein that causes the heart muscle
to contract.
Research on the health effects of air pollution continues to
be an active and crucial scientific effort. New epidemiologic
data strengthen the case for a link between exposure and
cardiovascular disease, as well as other conditions not
previously considered, such as adverse birth outcomes. As
these data accumulate, the need to understand how these
pollutants cause their effects becomes more important as well.
Agencies such as the National Institute of Environmental
Health Sciences (NIEHS) and EPA are currently funding
research, such as that described here at the University of
Louisville, to try to elucidate these mechanisms. The results
of this research cannot only lead to a reduction in the rate
of disease from air pollution exposure through enactment
of appropriate air pollution standards, but can also add to
our overall understanding of the causes and the pathologic
mechanisms of heart disease.

J. Patrick Mastin obtained he B.S. at Centre College,
Danville, KY., and his Ph.D. degree in Pathology at Duke
University. He took his first position with the NIEHS at
Cincinnati and subsequently moved to Research Triangle
Park, NC. where he is Chief of the Cellular, Organ and
Systems Pathobiology section.
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The Role of Metabolism in Protection Against
Cardiotoxic Compounds
Russell A. Prough, Immaculate Amunom, and Daniel J. Conklin
Department of Biochemistry & Molecular Biology and the Division of Cardiology,
Department of Medicine, the University of Louisville School of Medicine, Louisville, KY.
Abstract
Combustion of organic matter in the presence of oxygen leads to complete combustion forming CO2, water, and oxides.
Incomplete combustion leads for pyrolysis forming either fused ring molecules or unsaturated compounds, like acrolein and
formaldehyde. The unsaturated compounds are chemically reactive and directly alter cell growth and differentiation. The
fused ring compounds are chemically stable, unless metabolized by enzymes in our bodies to reactive intermediates. We have
evolved several families of enzymes which detoxify these reactive intermediates. This article will review how products of
pollution are formed, how they directly or indirectly react with biomolecules, and how they are toxic in the heart and other
vascular tissues.
Introduction
The concern that many products of combustion can cause
adverse biological effects in mammals has stimulated research
that provides a partial understanding of how compounds, like
benzo[a]pyrene (B[a]P), cause specific cancers, such as small
cell carcinoma. Like many other environmental chemicals,
B[a]P, in and of itself, is not chemically reactive, but must
be metabolically activated by enzymes in our cells. In the
case of B[a]P, a polycyclic aromatic hydrocarbon [PAH],
it has been well documented that it is formed during the
combustion of tobacco or other organic materials and has the
potential to cause cancer in animals and man. An elegant set
of experiments performed in the 1970s (Holder et al., 1974;
Selkirk et al., 1974; Kapitulnick et al., 1977; Levin et al.,
1986; Chang et al., 1987) documented that benzo[a]pyrene
requires metabolism in mammalian tissues to form the
ultimate carcinogenic agent. This reactive intermediate reacts
with specific DNA bases in target genes to form DNA-PAH
chemical adducts, thereby causing the critical somatic cell
mutations that lead to cancer. Many of these studies were
performed in animal models and a series of biological
oxidative reactions studied in these models were shown
to form the 9,10-epoxy-7,8-dihydrodiol-benzo[a]pyrene,
the ultimate carcinogenic form of B[a]P (Holder et al.,
1974; Levin et al., 1986). The realization that such reactive
intermediates are formed in our bodies with our own enzymes
has been a paradox to understanding the carcinogenicity
and/or toxicity of such compounds, since normally these
enzyme systems detoxify foreign compounds by converting
them to water-soluble, easily excreted metabolites. This
article will review some of the compounds formed during



the combustion process or inflammatory processes and how
they are detoxified on the one hand and cause environmental
disease on the other.
Compounds formed during the combustion process.
During the combustion processes associated with
open fires, burning tobacco products, and automobile fuel
combustion, organic materials are heated to extremely high
temperatures and sometimes at high pressures in the presence
of oxygen. Under conditions of complete combustion, i.e.,
in the presence of excess oxygen, most organic materials are
converted to carbon dioxide and water, while compounds
containing heteroatoms such as sulfur and nitrogen, are
converted to ammonia, SO2, nitrogen oxides, etc. Such
combustion reactions are known as complete combustion
reactions and normally produce new chemical products with
low chemical reactivity.
The energy associated with this process in the absence
of excess oxygen causes pyrolysis reactions that lead
to condensation reactions and formation of PAHs and
decomposition reactions to small, reactive organic molecules,
such as carbon monoxide (CO), acrolein and formaldehyde.
This process is known as incomplete combustion and often
forms chemicals with higher chemical reactivity. In addition,
toxic metal oxides are produced from the metals in the
organic material, such as arsenic used as wood preservatives,
lead in older paints, etc. Due to the intense temperature and
diverse conditions created during burning, both degradative
oxidation to compounds like carbon dioxide and water are
formed (expected during complete combustion). During
Fall/Winter 2006

incomplete combustion, unburned organics are formed
including fused ring compounds, such as the polynuclear
aromatic hydrocarbons, such as naphthalene, benzo[a]pyrene,
and chrysene or carbon monoxide, aldehydes like acrolein
and formaldehyde, sulfur dioxide, and nitrogen oxides
produced (expected during incomplete or partial combustion).
In the case of the smaller compounds, such as CO, sulfuric
acid, hydrochloric acid, hydrofluoric acid, nitric acids and
NO derivatives, these compounds can react with biological
molecules, like hemoglobin, cytochromes, glycolytic enzymes,
and alter their function; while the polynuclear hydrocarbons,
dioxins, and furans may be largely chemically inert under
these same conditions. Due to the diverse products formed
from fire or other smoke producing processes, molecules are
generated that either act directly to alter biological molecules
or subsequently become metabolically activated to reactive
intermediates by the enzymes in our body.
Electrophilicity and adduct formation: The chemical
nature of toxic organic materials.
The foreign compounds formed by combustion processes
can cause a number of responses. First, these compounds
cause direct chemical or toxicological reactions of the
electrophilic compounds formed during combustion. An
electrophilic agent is one which is electron deficient, such as
αβ unsaturated aldehydes (formaldehyde and acrolein), sulfur
dioxide or nitrogen oxides. These compounds react with
various cellular nucleophiles (electron-rich compounds), like
glutathione [g-glutamyl-cysteinyl-glycine], a tripeptide thiol
capable of reacting with reactive electrophilic compounds
which like to gain electrons into their structure (Figure
1). Thus, other biological nucleophiles, like proteins or
nucleic acids, can also form such adducts with electrophilic

Figure 2. The metabolism of polycyclic aromatic hydrocarbons. A. Naphthalene
and benzo[a]pyrene. B. The oxidation of naphthalene to form naphthalene oxide.
C. The reaction of glutathione with naphthalene oxide to form the glutathione
conjugate of naphthalene.

formed biologically when enzymes in our bodies catalyze
modification of various functional groups on other
compounds formed during combustion. For example,
combustion causes formation of PAHs during incomplete
combustion of organic materials, including cigarette smoke.
Examples of these compounds would include naphthalene
and benzo[a]pyrene (Figure 2A). In and of themselves, these
molecules are not chemically reactive, but upon metabolism
by oxidative enzymes known as monooxygenases, these PAH
can be converted into epoxides, compounds which are also
electrophilic in nature (Figure 2B). Like the αβ unsaturated
aldehydes, epoxides are capable of reacting with cellular
nucleophiles, such as glutathione, proteins and nucleic acids
of DNA (Figure 2C). So in summary, combustion produces
compounds that are either direct acting chemicals, like αβ
unsaturated aldehydes, or that require subsequent metabolic
activation to produce reactive chemicals, like epoxides of
polynuclear aromatic compounds.
The Body’s Defense: Mechanisms of foreign compound
elimination.

Figure 1. The reaction of the cellular nucleophile, glutathione or -glutamylcysteinyl-glycine, with the combustion product acrolein (2-propenal) to form
the GSH-acrolein conjugate.

compounds. The aldehydes described above are examples
of reactive electrophiles formed during the combustion
process that are directly reactive with biological materials
like proteins and DNA or the cellular nucleophiles.
These reactive chemicals are produced by the combustion
process; however, new reactive intermediates may be
Fall/Winter 2006

Many of the organic compounds produced by combustion
are fat-soluble and are taken up by our fatty tissues as a
storage depot. This is one reason that exposure of mammals
to foreign compounds is hazardous; i.e., their lipid-solubility
causes the compounds to accumulate in the body and be
stored for long periods of time. An example of this situation
is the storage of polycyclic aromatic hydrocarbons and
compounds like dioxin (formed both by forest fires and
by man) in the fatty tissues of our bodies after exposure or
ingestion of these materials. Without methods to remove these
compounds from the environment so they won’t accumulate



TABLE 1. Common enzymes involved in foreign compound metabolism

Enzyme

Reaction type

Reactant

Cofactor

Cytochrome P450

HydroxylaseEpoxidase

Molecular oxygen

Reduced pyridine nucleotides

Glutathone S-transferase

Thiol conjugation

Electrophile

Glutathione

Sulfotransferase

Sulfate conjugation

Phenol

3’-Phosphoadenosine 5’-phosphate

Glycosyltransferase

Glucuronidation

Phenol

UDP-glucuronic acid

N-acetyltransferase

Acetylation

Amines

Acetyl-Coenzyme A

Epoxide hydratase

Hydration

Epoxides

Water

in the body, we have to rely on a series of enzymes that aid
in the elimination of these compounds from the body. The
difference in the rate of accumulation of these compounds
in our fatty tissues and their elimination by metabolism to
more polar compounds dictates how fast they leave our body.
One way to describe the duration of retention of compounds
in our body is the term half-life, or the time it takes for Ω of
the body burden of a compound to be eliminated through the
kidneys or gastrointestinal (GI) tract.
Using a battery of enzymes that are oxidative, reductive
and/or conjugative (i.e., linking a water-soluble compound
to a fat-soluble compound) in reaction type, our organs,
especially the liver, can metabolize both direct and indirect
acting reactive chemicals by attaching an oxygenated
functional group to the molecule. Subsequently, other
enzymes add a water-soluble compound like a sugar, sulfate,
water, or glutathione to the molecules. In the pharmacology
literature, the oxidative/reductive enzymes have been termed
Phase I metabolic enzymes; the conjugative enzymes are
therefore termed Phase II synthetic enzymes. Finally,
there are processes that extrude these compounds or their
metabolites from the tissues into the blood stream, urinary
tract, or GI tract for disposition from the body; this process
is called transporter enzymes or Phase III enzymes. For most
chemicals, these reactions produce compounds which are
not toxic and by adding water-soluble molecules to these
oxygenated molecules, are made more water soluble. This
increased solubility allows these water-soluble materials to
be removed from fatty tissues and organelles in our liver
and other tissues and export them to the kidney or feces
for elimination. If the compounds formed have little or no
toxicity, then the compounds are rapidly and efficiently
removed from our body. These processes decrease the halflife of organic molecules in our body through enhanced
disposition after metabolism. Our livers are designed to be
very active in eliminating such compounds from the body
and serve as a “garbage system” for elimination of fat-soluble
compounds, both foreign compounds and endogenous
compounds, including cholesterol and fat.



The enzyme systems of importance that are involved in
eliminating such compounds are listed in Table 1 above. The
major oxidative enzyme encompasses a heme-thiolate protein
family containing over 100 distinct genes in mammals. It
carries out oxidation of carbon compounds by attaching an
oxygenated functional group that eventually can become linked
to water-soluble biomolecules, increasing the water solubility
of these combustion products. The sorts of water-soluble
molecules that are involved in conjugation reactions include
glutathione (-glutamyl-cysteinyl-glycine or GSH utilizing
glutathione S-transferases), glucuronic acid (UDP-glucuronic
acid utilizing UDP-glycosyltransferases), sulfate (3’phosphoadenosine 5’-phosphate utilizing sulfotransferase),
acetate (acetyl-CoA utilizing N-acetyltransferases), and water
(H2O utilizing epoxide hydratase).
Many of the metabolic processes in mammalian cells
have the ability to alter the expression of various genes
to compensate for times when more or less metabolism is
needed. These same processes exist in toxicology, since it
has been shown that an organism is highly sensitive to a
chemically-reactive material upon first exposure, but during
subsequent exposure to the compound less toxicity results.
This process is known as “tolerance” and can be explained
by a number of biological mechanisms. One part of this
process is known as “induction” and generally is due to an
increase in transcriptional activity of gene expression and
the accumulation of the protein catalysts in our tissues and
cells. This inductive process allows compounds to which
we are exposed to have the ability to increase their own
metabolism; through activating specific receptors in target
tissues like liver, these receptors function after chemical
exposure, like the sex steroids act through nuclear receptors
or transcription factors (Nebert et al., 2004; Whitlock et
al., 1997). One particular receptor is the Arylhydrocarbon
receptor (AHR) which is ubiquitously distributed throughout
the body (Figure 3). The PAHs formed during incomplete
combustion activate this receptor in those tissues that become
exposed to these materials. Upon entry into the cell and
binding to the AHR, the compounds cause the AHR to migrate
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transcription factor (also known as Nrf2) which is released
from a cytoplasmic protein complex upon binding of
electrophilic compounds. The subsequent accumulation of
Nrf2 in the nucleus activates another discrete set of target
genes important for increasing the concentration of other
enzymes, including GSH synthase, heme oxygenase, and
many other protective enzymes. This regulatory system is
involved in protecting against the direct acting chemicals
formed like NOx, αβunsaturated aldehydes, sulfur dioxide,
metals; i.e, the compounds also produced by the incomplete
combustion process.
Reactive chemicals cause abnormal cell growth and
proliferation.
In the past, considerable research has been directed
toward
understanding how toxic chemicals cause cancer.
Figure 3. The arylhydrocarbon receptor and its action. Polycyclic aromatic
hydrocarbons can passively diffuse into cells and interact with the Arylhydrocarbon The consensus is that foreign compounds are converted
receptor (AHR) in the cytoplasm. Activation of the protein complex associated with the to reactive electrophiles that can chemically react with
AHR causes a migration to the nucleus where it combines with the arylhydrocarbon
cellular nucleophiles like protein and nucleic acid to form
receptor nuclear transporter (ARNT) and bind to cognate responsive elements on
the 5-flanking region of genes. This leads to the production of mRNA’s capable of products known as adducts. Such reactions are believed to
encoding enzymes which detoxify compounds like benzo[a]pyrene to hydroxylated lead to toxicity by damaging proteins by forming protein
metabolites that are not toxic. These metabolites must also be easily excreted from
adducts or carcinogenesis by forming DNA adducts that
the body to diminish environmental disease.
result in somatic cell mutations and cancer. However, the
literature offers a second role for toxic chemicals in causing
to the nucleus of these target cells and activate a battery
abnormal cell proliferation and inflammation that results in
of genes involved in disposition of combustion products
formation of aberrant tissue growth and development, such
and other chemicals, eventually resulting in the increased
as atherosclerosis. Chemicals such as the a,b-unsaturated
expression of the messenger RNA and protein encoding the
aldehydes or reactive electrophilic intermediates of polycyclic
enzymes involved in foreign compound metabolism, such
aromatic hydrocarbons may be part of this second mechanism
as cytochrome P4501A1, UDP-glucuronosyltransferase, etc.
for causing disease in humans (Bhatnagar and Srivastava,
The enhanced excretion of the foreign compounds results
1992; Ramos et al., 1996; Moorthy et al., 2002). Aberrant
from this increased expression of the genes involved in
proliferation of vascular smooth muscle cells has long been
disposition of foreign compounds and enhances elimination
known to allow these cells to calcify and form plaque in
of these compounds from the body. These receptors often
arteries and aorta. This aberrant cell growth, accumulation of
also increase other biomolecules serving as protective
lipid and calcification eventually results in closure of vessels
agents for the body, like glutathione. The oxidative enzymes
leading to and throughout the heart, causing cardiovascular
also catalyze a limited number of reactions leading to
disease and atherosclerosis. Therefore, these exposures to
deleterious reactions, such as DNA and protein activation.
reactive chemical intermediates can not only cause cancer,
The paradoxical dichotomy of these enzymes’ action in
but also other chronic diseases like atherosclerosis, heart
activating a limited number of chemicals and their major role
disease and possibly other diseases like diabetes. This is
in eliminating most other chemicals, including those we take
schematized in Figure 4 showing that aldehydes, R-CH=O,
as drugs and beneficial compounds, causes us to be cognizant
like formaldehyde or acrolein formed by decomposition
of the importance of limiting our exposure to combustion
of volatile organic compounds cause toxic endpoints
compounds and other materials that may be bioreactive or
such as atherosclerosis, dyslipidemia (excess lipid in the
can be made bioreactive.
bloodstream), and endothelium dysfunction (inadequate
endothelial cell function). These lead to diseases like diabetes,
Many other ligand-activated nuclear receptors or
obesity, hypertension, etc.
transcription factors exist which can interact with foreign
compounds as well as endogenous compounds. Another
The research being pursued at the University of
important receptor is the NF-E2-related (Rushmore et al.,
Louisville in our laboratories focuses on how these disease
1990; McMahon et al., 2991; McMahon et al., 2003) nuclear
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states arise and how they can be prevented. Our particular
interest is to see how oxidative and reductive metabolism
may blunt these toxic events, protecting against aberrant
cell proliferation. A number of enzymes are involved in
these oxidation-reduction processes (Figure 4 and Table 2).
Aldose reductase (AR) or the aldo-ketoreductase (AKR)
enzyme families chemically reduce aldehydes to alcohols,
that tend to be less toxic than the aldehyde compounds. In
addition, aldehyde dehydrogenases use NAD(P)+ to oxidize
aldehydes to carboxylic acids. Both the alcohols and and
carboxylic acids can be conjugated with water-soluble
compounds that enhance excretion through the kidney or
into the bile. Recently, we have noted that the hemoprotein
family, cytochrome P450 (also know as CYPP450), can
also oxidize and reduce aldehydes to carboxylic acids and
alcohols as well (Amunom et al., 2005). This enzyme system
has high capacity to remove these foreign compounds and
appears to serve as a secondary system to protect the body
from aldehydes when the capacity of the reductases has been
attained.
Societal problems due to our reliance on modern
chemical and electrical conveniences.
As seen in the cover of this issue of Sustain, a paradox
exists in our modern life-style. The freeway shown with
vehicles moving rapidly through the hospital curve at
Louisville is a great benefit to our freedom to travel and
transport goods around our city at will. The electricity
produced by coal-fired power plants or products like hot water,
etc. to which we have become accustomed all require the use
of combustion of petrochemicals to maintain our lifestyles.
From the 1950s to the 1980s, we slowly realized that the
pollution formed from release of combustion processes like
the automobile engine or coal-fired power plants or chemicals
from our chemical plants pose a threat to our health through
a number of malignancies. With the advances in industrial
technology, workers are increasingly protected from direct
industrial exposure to such chemicals produced in West
Louisville. However, the wonderful freeway systems and
coal-fired power plants continue to expose us to pollution that

Figure 4. The role of metabolism in detoxification of aldehydes formed from
volatile organic compounds that lead to aberrant cell proliferation. AR, Aldose
reductase; AKR, aldo-ketoreductases; ALDH, aldehyde dehydrogenase; CYP,
cytochrome P450; VOC, volatile organic chemicals; R-CH=O, chemical formula
for an aldehyde.

appears to lead to deleterious diseases like atherosclerosis,
dyslipidemia, and perhaps even diseases like diabetes. The
coming decade will hopefully provide us with information
about how the environmental pollution we produce in our
modern lifestyle causes these emerging diseases threatening
our populace. In some part, the knowledge we gain about
how these processes work may allow us to prevent or treat
these diseases and increase the quality and quantity of life
for the Citizens of Louisville. However, this realization also
forces us to devise ways to decrease further the chemical and
particulate pollution we generate. Since all of these pollution
products affect health and cause environmental disease, the
other chapters in this issue will further document the role of
such chemicals in emerging environmental diseases.
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Table 2. Enzyme systems involved in oxidative-reductive metabolism of aldehydes formed from volatile organic compounds

Enzyme

Reaction

Coenzyme

Reaction type

Aldose reductase

Glucose ‡ Sorbital

NADPH

Reduction

Aldo-keto reductase

Aldehyde ‡ Alcohol

NAD(P)H

Reduction
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Ketone ‡ alcohol

Aldehyde dehydrogenase

Aldehyde ‡ carboxylic acid

NAD(P)+

Oxidation

Cytochrome P450

Aldehyde ‡ carboxylic acid

NADPH + O2

Oxidation
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ENVIRONMENTAL POLLUTION: RELATIONSHIP TO CARDIAC
DYSFUNCTION AND HEART DISEASE
Sumanth D. Prabhu, MD, FAHA, FACC
Professor of Medicine/Cardiology
Department of Medicine and Institute of Molecular Cardiology
University of Louisville School of Medicine
Louisville, KY.
Several pollutants are present in ambient air, and include
particulate matter (PM) and gases. PM is a complex, dynamic
mix of solid and liquid particles suspended in air. A large
array of chemicals has been identified in PM. Some of the
more common PM components include: 1) elemental and
organic carbon, nitrates, and sulfates; 2) organic compounds
such as aldehydes and polyaromatic hydrocarbons; 3) metals
and metal oxides; and 4) biological compounds including
bacterial products and pollen grains. Gaseous components
include nitrogen oxides, sulfur dioxides, carbon monoxide,
and ozone. PM is classified based on particle size; generally,
an aerodynamic diameter < 10 microns (termed thoracic
particles or PM10) can penetrate and deposit in the lungs
and are considered the most deleterious to health (Figure
1). According to current convention, PM10-2.5 particles are
referred to as the coarse fraction, PM2.5 and less as fine
particles, and PM0.1 and less as ultrafine particles. Ultrafine
particles have the potential for increased toxicity and may
even pass directly into the bloodstream from the lungs.
Pollutants arise from both man-made and natural

sources. Human-derived sources include industrial and fossil
fuel combustion, motor vehicle emissions, and environmental
tobacco smoke and are generally PM2.5. Natural sources
include windblown soil, forest fires, and bioaerosols and are
generally PM10-2.5. Ozone, a principal constituent of urban
smog, is formed via the effects of ultraviolet radiation from
the sun on both oxygen in the atmosphere and nitrogen
oxides and hydrocarbons derived from human activity. It
is important to recognize that PM composition is variable
over time and location, and that the adverse health effects
may be secondary to any one of the thousands of chemicals
that have been detected in PM. Indeed, determining the
precise effects referable to each constituent can be quite
difficult. Furthermore, although PM refers specifically to
air pollutants, many of its chemical constituents are also
found in other environmental sources. One such example
is a group of environmental pollutants termed aldehydes,
which comprise an area of active research interest at the
University of Louisville. While aldehydes are important
volatile components of PM2.5 and tobacco smoke, they are

Figure 1. Classification of particulate matter. Adapted from Brook et al./ AHA Scientific Statement # 71-0289,
URL: http://circ.ahajournals.org/cgi/content/full/109/21/2655/FIG1.
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ubiquitous and are also present in water and food. Thus, the
potential health effects of specific pollutants theoretically
should consider exposure derived from all environmental
sources.
The World Health Organization considers air pollution
as one of the top 10 causes of disability that accounts for
nearly 700,000 deaths annually. It is projected that if the
current pattern of fossil-fuel consumption and emissions
continues there will be nearly 8 million air pollution-related,
and potentially avoidable, deaths by the year 2020. From a
public health standpoint, while air pollution has classically
been recognized as an exacerbating factor for lung diseases
such as asthma and for the development of certain cancers,
the epidemiological link between environmental pollution
and heart disease has only been assiduously described in
the last several years, and thus the concept of pollution as a
risk factor for heart attacks, heart failure, and abnormal heart
rhythms has been slower to gain acceptance.
Several population-based studies have demonstrated
an important and potentially causative association between
both short-term and long-term human exposure to PM and
cardiovascular illness. These investigations have strong
implications for the formulation of regulatory policies
regarding acceptable levels of pollutants from human
activity such as industrial and automobile emissions. Shortterm studies have evaluated the relationship between recent
pollution exposure and adverse outcomes. Although these are
often analyses of heart disease in relation to the day-to-day
variation in air pollution (generally 1-2 day lag period), the
effects have been noted to persist when evaluated at longer
periods after exposure (e.g., > 40 days). The initial impetus
for such research was provided by the observation of higher
mortality rates during extreme elevations in air pollution.
During the London fog incident of December, 1952, for
example, there was a precipitous increase in air pollution
due to stagnant weather. Review of available hospital records
from that time suggested an excess of 12,000 additional
deaths over several months after the event due to both cardiac
and respiratory causes.
More recent epidemiological studies conducted in the
United States (National Mortality and Morbidity Air Pollution
Study [NMMAPS]) and Europe (Air Pollution and Health:
a European Approach [APHEA-2]) have shown remarkably
consistent associations between deaths due to heart and lung
diseases (i.e., cardiopulmonary mortality) and PM levels the
day before death. The overall increase in risk (~0.2-0.5% for
each increase in PM10 exposure of 10 micrograms/meter3)
is quite small compared to traditional risk factors for heart
disease such as cholesterol levels, high blood pressure,
Fall/Winter 2006
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diabetes, obesity, and cigarette smoking. However, since
air pollution exposure is ever-present, the absolute number
of people affected can be very large. For example, in one
analysis of the effects of PM exposure in the Netherlands, a
small European country, this 0.5% increase in risk translated
into an excess of at least 2100 deaths per year, twice the
number there due to traffic accidents. Direct associations
have been demonstrated between PM and chest pain and heart
attacks, heart failure and difficulty breathing, abnormal heart
rhythms and shocks delivered from implanted defibrillators,
and stroke. Recent studies have also indicated a relationship
between spending time in traffic and the risk of a heart attack
an hour afterward, and the level of ozone exposure and the
number of heart attacks within a period of 1 to 2 days.
Of equal significance, studies of long-term exposure to
PM have also demonstrated increased all-cause mortality, at a
level of 4% for every 10 micrograms/meter3 in annual PM2.5.
These investigations included the Harvard Six Cities Study
results published in 1993 and the American Cancer Society
Cancer Prevention Study published in 2004. Importantly,
cardiovascular deaths, and not respiratory illnesses, were the
single largest category of increased mortality due to chronic
PM exposure, and were linked to ischemic heart disease (i.e.,
heart attacks and angina), abnormal heart rhythms, heart
failure, and cardiac arrest. Studies on secondhand smoke
(SHS), the largest contributor to indoor PM, underscore the
chronic effects of PM exposure on cardiovascular health.
Nonsmoking spouses of smokers have an estimated 25%
increase risk of heart disease, and an estimated 2-fold increase
risk of stroke. A more vivid example of the impact of SHS
on heart disease was seen in June, 2002, when a public
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smoking ban was instituted in Helena, Montana. In the first
6 months of the ban, hospital admissions for heart attacks
dropped by 40%; this effect was not seen in hospitals from
surrounding towns. The totality of evidence thus implies a
causative link between ambient PM exposures and both acute
and chronic cardiac illness. Additionally, several groups of
individuals appear to be particularly vulnerable to these
effects. These include the elderly, those with pre-existing
heart and/or lung disease, those with diabetes, and those of
lower socioeconomic status. Active tobacco smoking also
increases the individual’s susceptibility to heart failure,
abnormal heart rhythms, and cardiac arrest due to pollution
exposure.
Although the epidemiological evidence linking PM
exposure and heart disease morbidity and mortality is
strong, much less is known as to precisely how PM exposure
engenders these effects. It is thought that fine air particles
may impact our heart and blood vessels in several ways.
They may have direct effects on the heart and arteries, as
particulates such as ultrafine particles, bacterial products,
and metals readily pass from the lungs after inhalation into
the bloodstream. Fine particles can also initiate generalized
inflammation in the body that can serve to constrict blood
vessels and promote the formation of blood clots, and
aggravate the progression of fat deposits in arteries. The
right combination of abnormalities in susceptible persons can
compromise blood flow in the arteries that supply the heart
or brain, resulting in a heart attack or stroke. In this regard, it
has been shown that short-term exposure to environmentallyrelevant concentrations of a mix of PM2.5 and ozone provokes
arterial constriction and narrowing even in healthy adults.

The development of strategies to reduce the cardiac
health risk from pollution exposure requires public health and
regulatory initiatives, as well as a scientific understanding
of the underlying mechanisms responsible for these effects.
From a population standpoint, more stringent regulation
of environmental pollution is the most effective method to
reduce adverse health effects associated with PM. This will
require intense effort and collaboration between several
groups including the public via their elected local, state and
federal legislators, industry, and the scientific community.
There also needs to be awareness of the potentially large
costs involved for air pollution abatement, and consensus
agreement as to what constitutes “acceptable” levels of
exposure. However, discovering the underlying mechanisms
is as important, especially for susceptible patient groups.
What may be a tolerable level of exposure for healthy
persons may produce adverse consequences in vulnerable
individuals. At the University of Louisville School of
Medicine, several researchers have been interested in
determining the specific biological mechanisms that account
for the association between environmental pollution and heart
disease. As discussed above, the chemical makeup of PM is
quite complex and a large knowledge gap exists regarding
the specific health effects referable to select chemical
constituents of PM. Due to several lines of epidemiological
and experimental evidence, we have been particularly
interested in a group of pollutants called reactive aldehydes.
Our research group wants to determine how these pollutants
affect the structure and function of the heart and the heart’s
ability to withstand reductions in blood flow, and how
pre-existing heart disease (due to heart attack) changes the
response to these pollutants.

PM inhalation can also alter the heart rhythm. Normally,
the heart rate has a given degree of variability due to cyclic
fluctuations in the output of the autonomic nerves to the heart
that regulate the heartbeat. Exposure to ambient PM reduces
this variability, perhaps related to the activation of neural
reflexes in the lung in response to injury or inflammation, and
the suppression of the normal output of the autonomic nerves.
While in healthy individuals these effects may go unnoticed,
in patients susceptible to heart arrhythmias significant
abnormalities in the heart rhythm, and perhaps even cardiac
arrest, can occur. This effect is particularly important in
patients with heart failure, as such patients already have
underlying abnormalities in the normal variability of the
heart rate and heightened susceptibility to abnormal heart
rhythms. Indeed, although death due to heart failure makes up
about 10% of all cardiovascular deaths overall, heart failure
deaths account for 30% of cardiovascular deaths related to
PM exposure.

We have an interest in aldehydes for several reasons.
First, aldehydes are ubiquitous pollutants. They are generated
during the combustion of fossils fuels, and are abundant in
automobile exhaust, cigarette smoke, natural and man-made
fires, and industrial waste, and are an important component
of PM. Specific aldehydes such as acrolein have also been
designated by the Environmental Protection Agency (EPA) as
high priority pollutants in drinking water, and others such as
hexenal are present in cooked foods and fats. Second, specific
aldehydes (acrolein is one example) can be particularly toxic
to biological systems. In the words of the EPA, “acrolein
is estimated to pose the highest potential on a nationwide
basis for significant chronic non-cancer effects.” Third,
exclusive of environmental exposure, all of us also generate
small amounts of these reactive aldehydes in our own body
during the course of normal metabolism – this balance can
be radically altered in diseases such as heart failure. Such
changes within the body may provide clues as to why certain
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groups of individuals are more susceptible to environmental
exposures of similar chemicals. Lastly, although several
experimental and epidemiologic studies hint that aldehydes
(derived either externally from the environment or internally
within the body) contribute to heart dysfunction and cardiac
disease, this relationship has not been systematically or
critically examined and is poorly understood. Therefore, it is
our intent to evaluate the consequences of aldehyde exposure
on the heart and to probe the specific mechanisms by which
this occurs.
Thus far, we have discovered several new and important
effects of aldehydes on the heart. We have seen that
acute exposure to acrolein, a model reactive aldehyde,
can profoundly depress heart function and also increase
the sensitivity of the heart to reductions in blood flow, or
ischemia. These effects are reversible and may be related
to selective effects of acrolein on the contractile proteins
and energy-generating systems of the heart. These types of
effects may be important during acute and/or occupational
types of exposures and suggest that such aldehyde-induced
effects can contribute to the reported increase in heart attacks
and dysfunction upon short-term pollution exposure. Just
as important, we have also determined that chronic oral
exposure to acrolein induces inflammation in the heart
resulting in the appearance of dilated and dysfunctional
heart tissue suggesting incipient heart failure. These findings
raise the intriguing possibility that environmental pollutants
may contribute to the development of cardiomyopathy
of otherwise undetermined origin. All of these studies
underscore the potential interactions between pollutants
(specifically aldehydes), heart dysfunction, and heart disease,
and constitute the first experimental evidence suggesting
that environmental aldehydes could trigger or affect clinical
cardiac disease. In the next few years, we plan to do further
experiments to expand on these early results, and develop
a working model for how aldehyde pollutants contribute to
and/or induce heart pathology.
In summary, the accumulating evidence supports
the notion that environmental pollution is a novel and
infrequently recognized risk factor for a variety of cardiac
diseases including heart attacks, heart failure, abnormal
heart rhythms, and sudden cardiac death. The mechanisms
may be related to direct effects, indirect effects due to the
induction of inflammation, and altered regulation of the heart
rhythm. The importance of specific pollutants in producing
adverse health effects is under active investigation; our
work suggests an important role for reactive aldehydes in
producing heart dysfunction, increased susceptibility to heart
ischemia, and heart failure. A focused effort on the part of the
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public sector, industry, and researchers will be required to
institute appropriate regulatory initiatives, and to combat the
underlying mechanisms responsible for pollution-mediated
heart disease.
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Getting to the heart of pollution: Is pollution a
new risk factor for cardiovascular disease?
Bradford G. Hill, Oleg Barski, and Aruni Bhatnagar
Institute of Molecular Cardiology, Division of Cardiology,
Department of Medicine, University of Louisville, Louisville, KY.
Abstract
Pollution from the combustion of fossil fuels has emerged as a major contributor to environmental deterioration and
human disease. Evidence accumulated over the last ten years supports an explicit link between heart disease and pollutant
exposure, and it is currently believed that the majority of deaths due to air pollution are due to cardiopulmonary diseases.
Thus, an understanding of how the constituents of pollutants in air, water, and cigarette smoke affect the cardiovascular system
is of primary importance. Accordingly, rigorous studies within our laboratories are shedding new light on the mechanisms
by which specific components of pollution contribute to heart disease.
Health effects of pollution are a growing concern
worldwide. Ever since the industrial revolution, we have
altered the environment in significant ways such that the
results of our activities have proven to be harmful to wildlife,
delicately balanced ecosystems, and our own health. We now
clearly know that polluted air and water do not only affect
rain forests and grasslands but also the risk, incidence, and
severity of some of the most serious of human diseases.
The extent of the problem or the degree to which pollution
contributes to the overall burden of human disease is not
known. It has been estimated that in 1997 alone there were
700,000 worldwide cases of avoidable deaths due to indoor
and outdoor air pollution. These deaths have been linked
to suspended particulate matter, largely from outdoor urban
exposures. This does not include deaths due to other sources
of pollution such as contaminated food or water. What is
even more alarming is that the World Health Organization
(WHO) estimates that by the year 2020 there will be eight
million deaths related to air pollution alone (1). The situation
is particularly grim in developing countries such as India
where deaths due to pollution exceed those due to cancer
and heart disease combined. The conditions in the developed
world are not much better. Early work by environmentalists
and concerned legislators has dramatically reduced the levels
of several pollutants (lead, mercury, second-hand cigarette
smoke), however, several toxic chemicals continue to pollute
our environment and their harmful effects are only now
coming to light. The most significant of these pollutants are
the air-borne particulates. These are small invisible particles
that are present in the air and are generated from human
activity. Coarse particles are created by actions such as the
grinding and grating of surfaces and the rubbing of tires on
the surface of roads, whereas the finer ones emanate from
automobile emissions and power plants (2;3).
Fall/Winter 2006

A pivotal study linking air particulates to adverse health
outcomes was published by a group of investigators from
Harvard in which they showed that people living in cites
with high levels of particulates had lower life expectancy
than people living in more polluted urban areas that had
subordinate levels of particulates. Their comparison was
based on data collected from six cities across the United
States and it showed that if you lived in Stubenville, Ohio
you could expect to die earlier than if you lived in Topeka,
Kansas (4). While the overall conclusion that pollution
affects life expectancy was not a big surprise, the startling
finding was the link between particulates and health
outcomes. These particles are present in the air everywhere
and are particularly high in urban areas. Does this mean that
everyone is at risk, and, if so, to what extent and how does
particulate air pollution contribute to chronic disease? The
answers have been slow in coming and even after fifteen
years of research and hundreds of published studies we have
only marginally addressed these concerns. We know that
particulate air pollution increases the incidence of cancer.
Moreover, it can exacerbate asthma, and people with chronic
lung disease are more susceptible to the harmful effects of
air pollution. However, research since the famous six-city
study has yielded another surprise. In analysis of the cause
of deaths that could be linked to air pollution, it was found
that most of the excessive deaths attributed to particulate air
pollution were due to heart disease (5).
The reason that the link between heart disease and
air pollution was surprising was that little was known
about how environmental pollutants affect heart disease.
Although there were a few studies linking heart disease
and exposure to solvents, cardiovascular toxicity was not
usually measured as an outcome of pollutant exposure, even
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in controlled laboratory conditions.
The reasons for such omission
are not clear but could relate to
the tacit assumption that the heart
and blood vessels were somehow
protected from the environment.
Overall, the emphasis was and is on
cancer and lung disease because of
the consequences pragmatic to air
pollution. Thus, there seemed no
reason to suspect that heart disease
could be negatively affected by
pollution. However decades of
research on cigarette smoke, which
is the most frequent toxic pollutant
to which humans are exposed,
indicate that quite the reverse may
be true.
Fig. 2: Risk of premature death from PM2.5 particles in ambient air (from Science 307, 1858-1861, 2005).

Fig. 1: Model PM10 distribution in the United States
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The unhealthy effects of
cigarette smoke have been under
scrutiny since the early 1950’s,
and we are only now beginning
to recognize the complexity of
mechanisms by which smoking
contributes to several diseases.
Nearly all of the initial studies
focused on the relationship between
cancer and smoking. However,
several studies clearly show that
smoking significantly affects heart
disease, and heart disease deaths
due to tobacco use far exceed
the number of deaths due to
lung cancer. In recent estimates,
smoking kills five to six times
more people by increasing heart
disease than causing lung cancer
(6). Fortunately, technology is now
allowing researchers to identify
thousands of compounds contained
within cigarette smoke, and these
investigations have already played a
role in the realization that voluntary
inhalation of cigarette smoke is
detrimental to the cardiovascular
system. More importantly, recent
studies are revealing that sidestream
(second-hand) smoke is drastically
more toxic than mainstream smoke.
Analyses in these investigations
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demonstrated that sidestream smoke is approximately four
times more toxic per gram than mainstream smoke, leading to
the conclusion that “smoke-free public places and workplaces
are the only practical way to protect the public from the
toxins in sidestream smoke.” Other studies have shown a
direct link between second-hand smoke and cardiovascular
disease, underscoring the evidence of smoking as the leading
cause of preventable death (7). While this has been known
for many years, it is only now that the full impact of these
data is coming into view. The lessons learned from the
health effects of smoking may be particularly useful as we
begin to probe how other air pollutants affect heart disease.
Cigarette smoke contains several pollutants present in
ambient air (e.g., particulate matter, butadiene and aldehydes)
that have been independently linked to heart disease (vide
infra), suggesting that their presence could precipitate
cardiovascular infirmities.
Overwhelming evidence accumulated over the last ten
years supports the link between heart disease and air pollution
(2;5;6). Over a hundred epidemiological studies have been
published showing that deaths due to heart disease increase
on days of high pollution. It has been shown that a sharp spike
in air borne particles is followed one to three or twenty-four
hours later by an increase in heart attacks. This relationship
has been found in many cities as different from each other
as Boston from London or New York from Los Angeles.
Further analysis of the cause of mortality showed that most
of the deaths were due to acute myocardial infarction (heart
attack), however deaths due to arrhythmias and heart failure
were also increased. The EPA estimates that of the 350,000
yearly cases of sudden cardiac deaths in the United States,
60,000 could be related to particulate air pollution (8). In

general, it is currently believed that 70 to 80% of excessive
deaths due to air pollution could be due to cardiopulmonary
causes (9).
Therefore, if we accept the data that air pollutants and
smoking increase the incidence of heart disease, then we are
left with the question why? Again, no one knows for sure.
Despite extensive epidemiological data published over three
decades, it is still not known how smoking increases the
incidence of heart disease. With particulate air pollution, the
problem may be even more difficult to solve. The particles
themselves vary greatly in size and composition and there is
little agreement between the experts as to which components
of the particles are causing the health effects. Thus, either
the particles themselves or some other pollutant (e.g.,
sulfates, ozone, or nitrous oxides) that increases in parallel
with particulate pollution could be causing the excessive
mortality.
To simplify the problem and to study it rigorously within
a laboratory setting, we have begun a series of studies on
the aldehydic components of urban air and particulates.
Aldehydes are reactive chemicals that are pervasive in our
environment (10). They are present in food – the crisp smell
of fresh fruit or spices is due to aromatic aldehydes such as
citral (in citrus fruit) and cinnamaldehyde (in cinnamon)
(Table 1-page 20). They are also responsible for the aroma
of cooked food and the putrid smell of rancid meat (11).
Aldehydes are also present in all types of smoke as they are
inevitably generated by combustion (Table 2 and 3-page
21). One of the most common of these is acrolein – which
is responsible for the acrid smell of smoke. Many aldehydes
are also present in urban drinking water supply streams, as
well as in streams, rain or fog. The EPA estimates
that, with the exception of metals, aldehydes are
the most prevalent pollutants in drinking water that
represent the highest health threat.
Not all aldehydes are bad, and several aldehydes
such as those present in herbs, spices, and fruits have
anti-inflammatory properties. Moreover, most of
the aldehydes ingested are efficiently removed by the
body by a variety of enzymes systems (e.g., aldehyde
reductase, aldehyde dehydrogenases, alcohol
dehydrogenases and glutathione-S-transferases)
that have evolved specifically to detoxify foreign
aldehydes. Thus, moderate aldehyde consumption
or exposure does not elicit any untoward effects.
However, persistent exposure to low levels of
environmental aldehydes such as those generated in
deep-fried food or cigarette smoke or those produced

Figure 3
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TABLE 1

Table 1: Aldehydes identified in foods
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TABLE 2

Table 2: Composition of aldehydes present in automobile exhaust

TABLE 3

Table 3: Levels of aldehydes in mainstream smoke of reference cigarettes

in the atmosphere from automobile exhaust and industrial
emissions could be particularly harmful.
For now, it is not known for certain whether aldehydes
in the atmosphere negatively impact human health and
what those affects are. However, there are tell-tale signs or
suggestions that exposure to aldehydes could be harmful,
particularly to cardiovascular health. Many studies have
shown that occupational exposure to aldehydes could
increase the risk for cardiovascular disease. These studies,
reporting an increased risk of atherosclerotic heart disease in
embalmers (12), undertakers (13), perfumery workers (14),
bus drivers (15), or workers in formaldehyde-producing
plants (16), support the view that exposure to aldehyde-rich
environments could be deleterious to cardiovascular health.
Indeed, the recent push to ban smoking in public places
such as restaurants and bars results from the realization that
second-hand smoke is capable of precipitating acute cardiac
events and may also negatively influence the chronic process
of atherogenesis.
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Exposure to industrial chemicals such
as butadiene and vinyl chloride has also
been linked to heart disease. In an extensive
study of workers in styrene-butadiene rubber
polymer manufacturing plants from 19431982, it was found that African-American
workers were at a two-fold higher risk of
developing heart disease than those who
did not work at the plant (17). Interestingly,
exposure to butadiene did not increase the
risk for heart disease in Caucasian workers.
These observations are of high local interest
in Louisville and surrounding areas since
there is a large rubber manufacturing plant
in our community. As a result, urban air in
areas of Louisville contains several times
the EPA permissible limit of butadiene.
While butadiene, which is also a component
of cigarette smoke, is well known to cause
cancer and trigger asthma, the realization that
it could cause heart disease adds new interest
in regulating its emissions and limiting
exposure. The notion that chemicals such as
butadiene could accelerate atherosclerosis is
supported by animal studies which show an
increase in atherosclerotic lesion formation
upon exposure (18). Interestingly, these
studies show that the amount of butadiene
required to increase heart disease was much
lower than that to cause cancer, suggesting
that an increase in heart disease may be a more common
or frequent outcome than cancer in people exposed to such
chemicals. A similar increase in the risk for heart disease
has been shown for workers exposed to vinyl chloride, which
is another chemical used in the rubber industry. A sevenyear study of 1,100 vinyl chloride exposed workers showed
that exposure to vinyl chloride significantly increases the
prevalence of high blood pressure and the incidence of heart
attack (19).
While neither butadiene nor vinyl chloride is an aldehyde,
we believe that the ultimate toxicity of these pollutants
is related to their conversion to aldehydes. Both these
compounds are metabolized by the body which converts them
to aldehydes and these aldehydes are in turn responsible for
the adverse cardiovascular effects associated with exposure
to vinyl chloride or butadiene. The main reason for concern
that aldehyde exposure could increase disease risk is that,
by their very nature, some of these aldehydes are highly
toxic. When delivered intravenously to animals, aldehydes
in low doses (1-10 mg/kg) prolong Q-T interval and cause
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of heart disease due to tobacco use, but also by significant
increases in cardiovascular diseases in populations exposed
to pollutants such as arsenic and ambient air particulates.
Collectively, even by conservative estimates, pollution may
be contributing to cardiovascular disease in several million
individuals. These estimates underscore the urgent need to
identify and control individual components of pollution that
affect the heart and blood vessels. Studies underway aimed at
determining how pollution affects heart disease will continue
to enlighten and remind us of how delicate and entwined our
health is with our environment.
arrhythmias and ventricular fibrillation. Depending on
the dose, they could increase or decrease blood pressure
(6). Aldehydes that stimulate stress responses or hormones
increase blood pressure, however, by themselves they lower
blood pressure. Indeed, one symptom of acute formaldehyde
poisoning is a rapid fall in blood pressure, causing flushing,
dizziness or even death.
Chronic exposure to aldehydes could have further
adverse effects on cardiovascular health. For instance, it has
been shown that animals fed aldehydes for several months
develop hypertension, increase platelet calcium and show
an increase in their heart weight, which is usually associated
with poor cardiac performance (6). Aldehydes also inactivate
important enzymes in the plasma which interferes with the
function of HDL (the “good” cholesterol) and thus could
elevate the risk of developing heart disease. Although such
data strengthen the rationale for studying the cardiovascular
effects of aldehydes, there is no firm evidence suggesting
that humans exposed to aldehydes are at a greater risk for
developing heart disease. However, our studies with animals
exposed to aldehydes are beginning to provide some insights
into how aldehydes could affect cholesterol levels, alter blood
pressure and decrease the ability of the heart to protect itself
from ischemia. Much work remains to be done, particularly
in establishing the relevance of animal studies to human
conditions.
Despite several unknowns in regard to the toxicologic
nature of specific pollutants, it is clear that air pollution from
current patterns of fossil fuel use is seriously affecting the
health of millions of people worldwide. In addition, pollutants
such as arsenic have caused arguably the worst toxicological
disaster in human history in several developing countries
(20-22). That air pollution could negatively impact human
health is well established, however, the surprising feature
of these new findings is that an increase in heart disease is
the most significant and widespread outcome of pollutant
exposure. This is borne out not only by the extensive burden
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Not magic, but mass spectrometry to monitor interactions of
environmental pollutants and the cardiovascular system
William M. Pierce, Jr, Jian Cai, Ned Smith,
Delano Turner, Kevin G. Taylor and Jason R. Neale,
Department of Pharmacology, Biomolecular Mass Spectrometry Facility,
Department of Medicine, University of Louisville, Louisville, KY.
Abstract.
As environmental cardiology continues to emerge as a subdiscipline, the tools of cardiovascular medicine and physiology
are integrated with the tools of toxicology and epidemiology. For molecular level studies, the most powerful tool available
is that of biomolecular mass spectrometry. This is a discussion of the historical developments and current applications of
mass spectrometry that enable such use. Mass spectrometric techniques and analytical strategies are shown to be useful in
molecular dosimetry studies, toxicokinetics and studies of mechanisms of action. Cardiovascular disease (CVD) is the number
one cause of death in most developed countries, accounting for more deaths in 2001 in the United States than cancer, diabetes
and accidents combined (Weinhold, 2004.) As with other diseases, a variety of causes can predispose or cause CVD, including
genetic predisposition, as well as lifestyle factors which are more controllable, including diet, exercise and other good health
care habits. In contrast to, for example, cancer, relatively little research has been accomplished examining potential roles of
foreign compounds (xenobiotics) in causing or exacerbating CVD. The newly emerging field of environmental cardiology
is beginning to address this area, with particular focus on the interactions of common xenobiotics encountered in developed
urban settings, such as chemical pollutants derived from various manufacturing and shipping processes and products of
combustion, including reactive xenobiotics, gasses, vapors and particulates. Some of these are known or suspected in the
etiology of CVD.
Questions in Environmental Cardiology
Environmental cardiology raises a special set of
toxicological questions concerning the interactions of
xenobiotics and the cardiovascular system, including:
• What are the identities of the xenobiotics to which
people are exposed?
• What is the nature of the exposure event? (Acute?
Chronic? To what doses and by what routes are they
exposed?)
• What is the fate of the xenobiotics when they enter the
body? Where do they go? What are they changed to?
How are they eliminated?
• What is the nature of the host-xenobiotic interaction?
What new molecules are formed and what are their
effects?
In order to study these phenomena at the molecular level,
sophisticated tools are needed. Of course, cardiopulmonary
medicine and related disciplines already provide tools of
electrophysiology and sonography for study of physiological
function that may be compromised by xenobiotic exposure.
To study the suspect molecules from the environment, we
have available the tools of analytic chemistry, especially
those of chromatography and spectrometry.
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The key molecules for study in environmental cardiology
are those that result from biotransformation (metabolism)
of xenobiotics and also newly formed molecules that result
from chemical reaction of a xenobiotics or its derivative with
proteins, nucleic acids (DNA, RNA), lipids (fats that make up
much of biological membranes) and other biomolecules.
The development of tools needed for sophisticated
analysis of the interactions between xenobiotics and
complex biomolecules has undergone an explosion over
the last generation. These tools include newly developed
techniques in chromatography and electrophoresis, but
the most important changes have been in application of
the techniques of mass spectrometry to the questions of
biomedical research.
Mass Spectrometry and its Development
Mass spectrometry (MS) has been used since the first
experiments of J.J. Thompson in 1899 . In studying “positive
rays”, Thompson was able to maneuver such radiation with
electromagnetic fields and to measure mass (For a brief
history, visit the Scripps website http://masspec.scripps.
edu/information/history/ ). Even to this day, the fundamental
mode of operation of mass spectrometry remains the same
as shown schematically in Figure 1:
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Figure 1. Schematic mass spectrometer. Although modern mass spectrometers
are marvels of engineering, ion physics and chemoinformatics, the fundamentals
remain the same.

Mass spectrometers are particularly useful because they
are universal detectors. That is, the only requirement for
an analyte is that it be made of matter. Mass spectrometers
analyze matter in the gas phase in a charged state (ions).
These ions (either positive or negative) are either introduced
or produced in the ion source region. By applying a large
voltage in this region, ions acquire kinetic energy and are
accelerated through the mass analyzer. There are several
types of mass analyzers which serve to measure, directly or
indirectly, the momentum of these ions as they travel from
source to detector. Momentum and kinetic energy are related
directly to mass, and an attached data system is able to acquire
data concerning the mass of these ions.
As we consider xenobiotics and biological molecules, it
would seem that mass is not a unique identifying property.
For example, nitrogen gas (N2) and carbon monoxide (CO)
each has a nominal molecular mass of 28 (14+14 or 12+16).
What we have learned from chemistry, however, is that
atoms do not have exactly integral mass values, and for this
example, the true masses are for CO 27.995 and for N2, m/z
28.006. Many mass spectrometers can readily measure this
difference and thus can distinguish the two gasses. This is
equivalent resolution to that required to distinguish a 150
pound individual from another who weighs 150.06 pounds.
In addition to this ability to measure masses very accurately,
mass spectrometers have a very wide dynamic range, capable
of mass measurement up to molecular masses of millions of
Daltons.
To be useful for studies of part per billion pollutants
diluted into 50-100 kg animals (adult humans), mass
spectrometers must be very sensitive, able to measure small
amounts of analyte. This is indeed the case, with some MS
instruments capable of measuring 1000 or fewer molecules.
This is very few indeed, as can be shown by a simple thought
experiment. Take the U.S. national debt ($8.2 trillion and
counting) and give that much money to every man, woman
and child on the planet (6.58 billion and counting.) Try to
imagine that amount of money, then realize that a teaspoonful
of water has twice that many molecules of water!
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Mass spectrometers have one more capability which
gives them enormous power in structural analysis. Not only
are MS instruments able to sensitively and accurately measure
the mass of the molecules introduced into the ion source, but
these instruments usually have a means for exciting analyte
molecules to induce decomposition into fragments of these
molecules. The masses of these fragments can be determined.
This pattern is similar to a fingerprint, allowing one to deduce
the structure of the analyte.
This ability to identify unknown compounds from crude
mixtures of traces of analyte has lent a mystique to the use
of mass spectrometry as a “magic black box” capable of
detecting anything. Earlier television programs such as
Quincy, M.E., and current programs such as C.S.I. and Law
and Order are wildly popular, and often rely on the use of
mass spectrometers. A small drop of fluid is introduced into
the instrument (Figure 2) and instantly, a pattern of peaks
appears on a computer screen, followed by dialog like, “This
spectrum clearly shows that the perp stopped at a truck stop
in Tucson, had a bagel with apricot preserves and a skinny
mocha latte immediately before raping and murdering Ms.
Smith, who was wearing a lavender seersucker suit and
chewing cinnamon gum at that time.”
“That’s it, Johnson is our man. Bring him in.”

Figure 2. A whimsical example of using MS technology as “black box
magic.”

While this is very successful entertainment, it bears
no resemblance to reality, and actually creates exaggerated
expectations for mass spectrometry.
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Modern Biomolecular Mass Spectrometry
All of the properties discussed above were available to
scientists in the 1950s, yet biomolecular mass spectrometry
(the application of MS to study of biomolecules) has only
recently become commonplace. That is because such
application awaited several developments in companion
sciences.
Several advances in technology and prevailing scientific
paradigm since the 1980s have enabled everyday use of mass
spectrometry in biomedical sciences. These contributions are
shown schematically in Figure 3.

Figure 3. Scientific and technological changes since the 1980s have enabled
everyday use of mass spectrometry in biomedical sciences.

Early mass spectrometers had paper strip output and
mass assignments were made using a mix of pencils, rulers,
graduate students and coffee. Although tedious, no other
method could rival this. Modern mass spectrometers are
operated using high speed computers with vast data storage
capabilities, allowing sample collection in the GHz range
(billions of scans per second.)
Dramatic advances in
data handling, and studies of very large data sets (see large
scale biology below) have been the impetus for the rapid
demand and growth in the fields of chemoinformatics and
bioinformatics. These are disciplines which develop and
use computational and statistical analysis of large data sets
to infer chemical and biological meaning.
The need for new tools and approaches of informatics
became very clear as the human genome project developed.
The very large sets of data available were powerful tools in
the hands of those able to use them. For this project, the
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goal was definition of the entire human genome – that is
the structure of all of the genes and chromosomes. As this
unfolded, other scientists argued that the relatively static
genome serves as a blueprint, and while it is important, the
complementary proteome (the structure of all of the proteins
in a cell) is important in understanding regulatory biology.
This is because the proteins are the molecules that provide
structure in the cell and the proteins serve as catalysts to
manage the chemical reactions within a cell. Finally, the
discipline becoming known as metabolomics completes the
picture, seeking to take a moment-to-moment snapshot of the
smaller molecules (metabolites) in the cell. The attempt to
study all of these phenomena simultaneously is called systems
biology. Mass spectrometry is one of several technologies
critical to this field.
The key technical advancement that has enabled
biomolecular mass spectrometry is the development of socalled soft ionization techniques. Earlier MS instruments
were not useful for proteins, nucleic acids, carbohydtaes
and the like because of the harsh conditions used for
vaporization, ionization or both. With the development of
electrospray ionization (ESI) methods and laser desorption
ionization (LDI) methods, this barrier was removed. These
developments were sufficiently significant that John B.
Fenn of Virginia Commonwealth University (ESI) and
Koichi Tanaka of Shimadzu Corporation (LDI) received
a portion of the 2002 Nobel Prize in Chemistry “for their
development of soft desorption ionisation methods for mass
spectrometric analyses of biological macromolecules.” Later
work at the University of Frankfurt by Franz Hillenkamp and
Michael Karas led to the development of a matrix. It is the
development of ESI and MALDI that opened the door for
biology to use mass spectrometry.
Aldehyde Pollutants and Analytical Strategy
Of the 300,000 or so sudden cardiac deaths each year, it
is estimated that perhaps 20% are due to acute air pollution
exposure. The cause and effect relationship, as well as the
mechanisms of action are not clear.
The Environmental Cardiology team at the University
of Louisville is examining a particular chemical class, the
aldehydes, for their effects on molecular, cellular or systemic
function. Aldehydes are a group of chemicals that can be
found in high quantities in vehicle exhaust fumes and cigarette
smoke. In this context, they are the products of incomplete
combustion. In addition, these chemicals are also found in
fried foods, fats and drinking water. The projects currently
underway seek answers to four basic questions regarding the
cardiotoxicity of aldehydes:
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• How do cardiovascular tissues metabolize aldehydes
and how does the cardiovascular system handle the
challenge of foreign chemicals?
• How, and how quickly, do aldehydes accelerate the
progression of heart disease?
• How do aldehydes interact with blood cells to cause
cardiac and vascular inflammation?
• How do high levels of aldehydes raise the risk of heart
attack and worsen heart failure?
The principal uses of mass spectrometry for molecular
level analysis for these projects are in the areas of (1)
molecular dosimetry, (2) toxicokinetics and metabolism and
(3) mechanisms of toxicity.
Molecular Dosimetry
All of us are frequently exposed to a variety of aldehydes,
from the environment (foods, water, air) and from normal
metabolism, especially that of fats. These projects focus
on the more highly reactive αβ unsaturated aldehydes, and
particular attention will be paid to hexenal, 9-hydroxynonenal
and acrolein. The need for a molecular dosimeter (a molecule
whose presence and concentration reflect exposure) is
several-fold. It is important to be able to mimic exposures
that are realistic in comparison to real human exposures. It
is important to know how to correlate exposure to risk of
toxicity. It is important to have an analysis that allows us to
monitor human exposure and to identify people at risk for
developing cardiotoxicity. Finally, it is equally important
to develop an analysis that can provide, with confidence, a
means of reassuring the “worried well”, those with potential
exposure to aldehyde sources or at risk for cardiotoxicity who
have not sustained a toxic exposure.
For molecular dosimetry and for inhalation toxicology
in vivo we will develop a molecular dosimeter that will do
one of the following:
• Quantitative measurement of acrolein in blood plasma
using gas chromatography/MS analysis, or
• Quantitative measurement of small molecule that
serves as “sink” for acrolein, but is readily excreted
(for example, ascorbate or glutathione)
• Quantitative measurement of an extracellular protein
that serves as “sink” for acrolein (this may be any
abundant plasma protein)
These studies will be accomplished using GC/MS and
LC/MS.
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Toxicokinetics
For toxicokinetics, this project will identify and quantify
metabolites of αβ unsaturated aldehydes, will study the rate
of elimination of parent compound and metabolites, and will
monitor especially those formed with ethanolamine, globin
or albumin.
Mechanistic Studies
For mechanistic studies, understanding of chemistry of
reactions of αβ unsaturated aldehydes and identification of
targets will result in the following:
• Studies of mechanisms and kinetics of reactions of αβ
unsaturated aldehydes and model peptides
• Performance of expression proteomics experiments to
identify candidate proteins
• Use of cardiovascular function tests to suggest
candidate protein targets
• Studies of mechanisms and kinetics of reactions of
αβ unsaturated aldehydes and candidate proteins or
nucleic acids
Analytical Strategies
Given the rich variety of mechanisms and potential
number of target molecules, there are only a few different
types of studies that will be performed. In anticipation
of animals exposed via the inhalation route, preliminary
experiments have been performed to demonstrate feasibility.
These analyses are designed to study the fate of aldehyde air
pollutants in the body: (1) GS/MS analysis for low molecular
weight and volatile analytes, (2) expression proteomics,
(3) model peptides and aldehyde reactivity, (4) MS protein
analysis for identification of proteins and sites of adduct
formation and (5) methods for analysis of DNA adducts.

Figure 4. For this analysis of a single tissue extract, more than 4000 mass
spectra were obtained. Each peak in this chromatogram corresponds to a
single compound which can be identified by mass spectrometry (Srivastava
et al., 1998).
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GC/MS Analysis of low molecular weight species.
Methods for analysis of aldehydes using GC/MS have
been published by this group and an example chromatogram
is shown in Figure 4. In principle, each of these peaks can
be identified using mass spectrometry.
GC/MS analyses are useful for a variety of applications
in these projects. Examples include:
• Direct dosimetry – for some airbourne pollutants,
measurement of the amount in the bloodstream will
be the best measure of the delivered dose of the
xenobiotics. Alternatively, endogenous metabolite
adducts (lipids, carbohydrates, etc.) may be identified
this way
• Exposure and risk – if this is indeed useful as a measure
of delivered dose, then workers in the chemical
industry, neighbors of such industry and others will
have a simple test availale to demonstrate such
exposure, which will guide treatment.
• The “worried well” – in the case of known or purported
exposure to an area, there will almost always be a large
group of the “worried well” those at risk who have not
experienced significant exposure or risk. These can be
reassured by negative findings of such tests.
MS Analysis of Protein-Adduct formation
Many xenobiotics are sufficiently reactive that they will
form adducts with endogenous proteins. Such adducts are
useful “biomarkers” of exposure. MS techniques are useful
for discovery and monitoring of such biomarkers.

Figure 5. Proteins were extracted from tissues samples and separated using high
resolution 2D PAGE analysis followed by MALDI-TOF mass spectrometric analysis
of tryptic digests. Red dots designated protein “spots” that were identified using
mass spectrometric patterns. Yellow spots have been selected for continuing
study because the expression level is either higher or lower than control, but
initial studies failed to identify them (Gozal et al., 2002)

Expression proteomics - One way to discover useful
biomarkers formed as adducts of aldehydes is to attempt to
study all available proteins from a tissue, before and after
exposure to air pollutants. Data shown below in Figure 5 are
from a report of the use of protein mass spectrometry to study
oxygen sensitive pathways in regulatory biology. In this
study, expression proteomics analysis using two dimensional
electrophoresis and mass spectrometry was able to identify
several altered proteins. After electrophoretic separation,
each protein can be taken for MALDI peptide fingerprinting
or further structural analysis.

Model peptides and aldehyde reactivity - One approach is
to study the chemistry of the reactivity of known aldehydes.
Studies using acrolein and hydroxynonenal (HNE) have
shown that the unsaturated aldehydes are indeed highly
reactive toward peptide thiols and primary amines. For the
following group of peptides and reactivity toward acrolein,
the highlighted residue was the principal site of reactivity:
EGVYVHPV
PKPQQFFGLM-NH2
CDPGYIGSR
SVSEIQLC
RGPCRAFI
Figure 6

28

Fall/Winter 2006

Peptide fingerprinting and partial sequencing
The use of MS techniques to identify proteins and study
their structure, especially in cases of large scale biology
design, is to obtain as much information as possible as
efficiently as possible. Often a three tiered approach is used,
as shown in Figure 6.
For peptide mass fingerprinting, a sample (usually
excised from a gel or in solution as a column effluent) is
treated with an endoproteinase, such as trypsin, which cleaves
the protein into a few dozen smaller peptides. These are
typically analyzed using MALDI and time-of-flight MS.
The data obtained are the masses of the peptides. Since we
know where the enzymes cleave (trypsin leaves an arginine
or lysine on the carboxy terminus), we can go to a protein
data base, and compare our data to all of the known proteins.
A laboratory can perform hundreds of such analyses per
day. Any adduct formed will have an altered mass and can
be tentatively identified. If this approach is inadequate,
tandem MS (two in-line MS systems) is used to determine
the sequence of one or more peptides. Some proteins have
as many as 500-1000 amino acid residues and typically
no effort is made to determine all of these in a de novo
sequencing study. If 7 consecutive residues in a peptide
can be determined (this is often readily accomplished),
this sequence can be used to interrogate a known genome
(such as homo sapiens) asking he question “Where is this
sequence found?” Even though this is a minor fraction
of the protein’s sequence, the random chance of finding 7
consecutive residues is less than 1 in a billion (207)! If this
fails, de novo sequencing may be necessary. Combinations
of these techniques yield identification of the protein, of the
adduct and the site and amount of adduct formation.
As data accumulate concerning which proteins are
modified by exposure to environmental compounds, molecular
mechanisms can be deduced. For example, changes in
inflammatory pathway proteins and/or lipid carrying proteins
are likely to influence plaque formation and may increase
the risk of myocardial infarction or stroke. Modifications
of excitable cardiac tissue proteins or signal transduction
proteins may lead to dysrhythmmias. Modifications of
cytoskeletal proteins may underlie diminished cardiac output.
This is the point for integration of physiological data and
molecular level findings.

Figure 7

in others, to apoptosis or necrosis and in the worst cases, a
mutagenic and ultimately a carcinogenic effect.
To examine this possibility, DNA samples were
hydrolyzed to yield nucleosides, then taken for LCMS
analysis to elucidate the structure of the aminobiphenyl
adduct of deoxyguanosine as shown in Figure 7. (Neale,
J.R., unpublished data.)Such analyses allow prediction or
verification of mechanisms of toxicity.
While mass spectrometry is not a magical black box that
can discover and prove everything (sorry CSI!) it is a very
valuable tool for elucidation of toxicological mechanisms in
environmental cardiology.
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